Matinas BioPharma Holdings, Inc. (AMEX: MTNB) last traded at $2.87, up 1.41% on the session. The quote above updates while this page is open; the figures below are drawn from Matinas BioPharma Holdings, Inc.’s own filings and are restated only when a new one is published.
Matinas BioPharma Holdings, Inc. trades on AMEX under the ticker MTNB. Its market capitalisation is $42.17 million.
Valuation measures for Matinas BioPharma Holdings, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $42.17M |
|---|---|
| Enterprise value | $43.02M |
| Price / book | 23.43 |
| Beta | -13.74 |
Trailing-twelve-month figures tagged in Matinas BioPharma Holdings, Inc.'s XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$6.69M |
| Return on equity | -371.72% |
|---|
| Cash | $761.0K |
|---|
Range and volume for MTNB over the past 52 weeks.
| 52-week high | $28.95 |
|---|---|
| 52-week low | $2.27 |
| Volume | 34.8K |
| Average volume | 5.18M |
| Previous close | $2.83 |
Invest a chosen dollar amount in Matinas BioPharma Holdings, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MTNB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.